Tag Archives: #AdComm

“Can You Hear Me?” – The (Hopefully) Coming Transition from Virtual Meetings

Posted on March 26, 2021 by Mark Senak

Today, FDA published notice in the Federal Register of an upcoming meeting of the Arthritis Drugs Advisory Committee that will be held May 6. The meeting will be held virtually. Last year when the pandemic reality started setting in, like … Continue reading →

Posted in Advisory Committee Prepapartion, Current Affairs | Tagged , , | Comments Off on “Can You Hear Me?” – The (Hopefully) Coming Transition from Virtual Meetings

FDA to Hold Virtual AdComm

Posted on July 8, 2020 by Mark Senak

I don’t usually publish the scheduling of an AdComm with a blog posting. But this one merits one. With fewer than the usual minimum of fifteen days’ notice, FDA has scheduled an FDA Advisory Committee meeting of the Cardiovascular and … Continue reading →

Posted in Advisory Committee Prepapartion, FDA Image, FDA Policy | Tagged , , | Comments Off on FDA to Hold Virtual AdComm